===
EQS Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back Program - 4th Interim
Announcement
Share Buy-Back Program - 4th Interim Announcement
2024-04-22 / 17:17 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014
(MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 4th Interim Announcement
In the period from April 15, 2024 until and including April 19, 2024, CompuGroup Medical SE & Co. KGaA has bought back
an aggregate number of 106,540 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had
been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start
on March 26, 2024.
The aggregate number of shares bought back each day during the period from April 15, 2024 until and including April 19,
2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:

Date          Aggregate volume (number of no-par value Volume-weighted average price (in EUR, excluding ancillary costs 
shares)                                  and charges) 
April 15,     21,350                                   29.9373 

2024
April 16, 34,343 29.0553
2024
April 17, 10,000 29.2615
2024
April 18, 20,847 29.1385
2024
April 19, 20,000 29.0579
2024
Total: 106,540 29.2682 The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including April 19, 2024 amounts to 380,536 shares. Detailed information about the transactions are published on the company's website under https://www.cgm.com/corp_en/ company/ir-en/share.html . The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 22, 2024 CompuGroup Medical SE & Co. KGaA The general partner
===
-----------------------------------------------------------------------------------------------------------------------

2024-04-22 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      CompuGroup Medical SE & Co. KGaA 

Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

End of News EQS News Service
===
1886319 2024-04-22 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1886319&application_name=news

END) Dow Jones Newswires

April 22, 2024 11:18 ET (15:18 GMT)